Alzheimer's vaccine triggers brain inflammation when brain amyloid burden is high
Patients with Alzheimer's disease who are in the early stages of their illness will likely benefit most from vaccine therapies now being tested in a number of human clinical trials, say researchers from Georgetown University Medical Center (GUMC).
Their study, presented at the annual meeting of the Society for Neuroscience, Neuroscience 2011, is the first to show that mice with a large brain burden of amyloid protein -- representative of many patients now receiving immunization -- were much more likely to experience significant brain inflammation. In contrast, mice with less amyloid in their brains did not experience this side effect, and showed a significant benefit from the vaccine.
Inflammation is associated with brain swelling, (also known as encephalitis or vasogenic edema), and is found in a small subset of Alzheimer's disease patients enrolled in ongoing vaccine trials, says the study's lead investigator, R. Scott Turner, M.D., Ph.D., director of the Georgetown University Memory Disorders Program. Turner is both a laboratory scientist and a neurologist who treats individuals with dementia due to Alzheimer's. He is a lead investigator of clinical studies examining new therapies including vaccines.
While patients often don't know they have this side effect and have no symptoms, the swelling can be seen on MRI scans that are routinely performed on patients enrolled in these trials, he says. "Excessive inflammation, however, is counter-productive because it will limit the benefits of the vaccine treatment, and in a few cases, will cause new problems," Turner says.
The study is important, he says, because it shows that excessive inflammation occurs in brains that have a high burden of amyloid, suggesting that benefits from the vaccine will most likely be found in those with a lower amyloid burden. The study also provides clues as to how and why the inflammation occurs, Turner says. Such studies defining inflammatory mechanisms in the brain are not possible in Alzheimer's patients undergoing these treatments.
Active immunization involves injecting amyloid protein in patients so they can mount an antibody response (similar to getting a flu shot). Amyloid is the protein that builds up in the brains of Alzheimer's patients and is thought to be the primary cause of the disease. Passive immunization involves infusing monoclonal antibodies intravenously so they can attack amyloid build-up in the brain. Inflammation is an expected part of the body's immune response in both of these vaccine strategies, but excessive inflammation can be harmful, Turner says. He undertook the study in a mouse model of Alzheimer's to understand if amyloid burden plays an important role in the degree of inflammation generated in response to passive immunization treatments.
Given the study findings, he says that the vaccines now being tested in patients with Alzheimer's may work better in patients with mild cognitive impairment, which is a precursor of Alzheimer's. Consistent with this notion, a new clinical trial testing active immunization in mild cognitive impaired (MCI) patients (with a positive amyloid PET scan) is now recruiting volunteers at GUMC.
"We may find that in the future, we will have to tailor immunization therapies based on amyloid burden in individual patients," Turner says. For example, in order to minimize the risk of excessive inflammation in brain, the antibody dosage with passive immunization treatments may be limited in those individuals with a higher amyloid burden.
Provided by Georgetown University Medical Center
- Vaccine slows progression of skeletal muscle disorder May 13, 2009 | not rated yet | 0
- Award-winning research points toward Alzheimer's vaccine Sep 26, 2011 | not rated yet | 0
- Alzheimer's vaccine clears plaque but has little effect on learning and memory impairment Apr 04, 2008 | not rated yet | 0
- Development of a safer vaccine for Alzheimer’s disease Nov 17, 2010 | not rated yet | 0
- Scientists find new cause of Alzheimer's Apr 19, 2006 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Image of a Convex Lens Cut in Half Horizontally
2 hours ago Hello everyone, A friend of mine came up with this question in class and I really do not have a good answer. Suppose you have a convex lens...
Ray tracing throught optical system of thick lenses
2 hours ago Can you advise me a free software that allow to draw rays passed throught system of thick lenses (preferable in 3D)?
Faraday's law on circular wire
3 hours ago In my examples on Faraday's law in my book, they use a drawing of a magnet approaching a circular wire. The changing magnetic flux then induces an...
Specific Exergy vs Specific Flow Exergy
4 hours ago I'm having some difficulty understanding exactly what the difference between the definitions of these values are. As I understand it, in terms of...
The Durability of Bone: Long Falls
13 hours ago I am doing a paper on the physics in Valve's Portal and got interested in the "Long Fall Boots" that prevent any damage no matter how far you fall. I...
Is energy convertible to matter?
14 hours ago Can we convert energy to matter?
- More from Physics Forums - Classical Physics
More news stories
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
Alzheimer's disease & dementia 21 hours ago | 5 / 5 (6) | 0 |
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Alzheimer's disease & dementia May 20, 2013 | 5 / 5 (4) | 0 |
A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.
Alzheimer's disease & dementia May 19, 2013 | 5 / 5 (3) | 0 |
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
Alzheimer's disease & dementia May 19, 2013 | not rated yet | 0
(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...
Alzheimer's disease & dementia May 17, 2013 | 5 / 5 (2) | 0 |
The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...
21 minutes ago | not rated yet | 0
Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, ...
1 hour ago | 4 / 5 (1) | 0
Is it permissible to harm one to save many? Those who tend to say "yes" when faced with this classic dilemma are likely to be deficient in a specific kind of empathy, according to a report published in the scientific journal ...
6 hours ago | not rated yet | 0 |
(Medical Xpress)—Scientists supported by the National Institutes of Health have a new theory as to why a woman's fertility declines after her mid-30s. They also suggest an approach that might help slow ...
3 hours ago | not rated yet | 0 |
Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens
Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...
7 hours ago | not rated yet | 1 |
Medical researchers discover new ways to target, develop and design drugs to prevent and treat viral infection
Researchers at the University of Alberta have discovered a new drug target, developed a new drug and identified a new way to design drugs—all of which could be a winning combination in the battle against viruses.
3 hours ago | 4 / 5 (1) | 0 |